Prognostic value of systemic inflammatory response index in patients with acute coronary syndrome undergoing percutaneous coronary intervention

• Published in: Annals of medicine (Helsinki) Vol. 54; no. 1; pp. 1667 - 1677
• Main Authors: Han, Kangning, Shi, Dongmei, Yang, Lixia, Wang, Zhijian, Li, Yueping, Gao, Fei, Liu, Yuyang, Ma, Xiaoteng, Zhou, Yujie
• Format: Journal Article
• Language: English
• Published: England Taylor & Francis 31.12.2022; Taylor & Francis Group
• Subjects: acute coronary syndrome; Acute Coronary Syndrome - complications; Cardiology & Cardiovascular Disorders; cardiovascular outcomes; Humans; percutaneous coronary intervention; Percutaneous Coronary Intervention - adverse effects; Percutaneous Coronary Intervention - methods; Prognosis; Risk Assessment; Risk Factors; Systemic inflammatory response index; Systemic Inflammatory Response Syndrome - epidemiology; Systemic Inflammatory Response Syndrome - etiology; Treatment Outcome; percutaneous coronary intervention; acute coronary syndrome; cardiovascular outcomes; Systemic inflammatory response index

The systemic inflammatory response index (SIRI) is a novel inflammatory biomarker in many diseases. The aim of this study was to examine the association between SIRI and adverse events in patients with the acute coronary syndrome (ACS) undergoing percutaneous coronary intervention. A total of 1724 p...